A Study of YL202 in Selected Patients With Advanced Solid Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is a multicenter, open-label, phase II study of YL202 in China to evaluate the efficacy, safety, and PK characteristics of YL202 in the following selected patients with advanced solid tumors.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Świadoma zgoda na uczestnictwo w badaniu – osoba musi być poinformowana i dobrowolnie podpisać formularz zgody.
- •Wiek od 18 do 75 lat (włącznie).
- •Potwierdzony nowotwór (rak płuca, piersi, głowy i szyi lub inne zaawansowane guzy, np. jelita grubego, żołądka, szyjki macicy, jajników).
- •Co najmniej jeden guz widoczny na badaniach obrazowych (poza mózgiem).
- •Możliwość dostarczenia próbki nowotworu (archiwizowanej lub świeżej).
- •Ogólny stan zdrowia oceniany na 0 lub 1 punkcie (zdolność do codziennych czynności).
- •Prawidłowe wyniki badań krwi i funkcji narządów (wykonane do 7 dni przed badaniem).
- •Spodziewany czas przeżycia co najmniej 3 miesiące.
✗ Disqualifies
- •Wcześniejsze leczenie lekami działającymi na HER3 (przeciwciała, leki conjugate, immunoterapia CAR-T).
- •Nieprawidłowa tolerancja wcześniejszych leków z grupy inhibitorów topoisomerazy I lub podobnych terapii.
- •Jednoczesne uczestnictwo w innym badaniu klinicznym (z wyjątkiem badań obserwacyjnych).
- •Zbyt krótki czas od poprzedniej terapii przeciwnowotworowej.
- •Poważna operacja w ciągu ostatnich 4 tygodni lub planowana podczas badania.
- •Wcześniejszy przeszczep szpiku lub narządu stałego.
- •Ostatnie leczenie kortykosteroidami (prednizon >10 mg/dobę) lub immunosupresją w ciągu 2 tygodni.
- •Szczepienia żywymi wirusami w ciągu 4 tygodni lub planowane podczas badania.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- November 26, 2025
- Sex
- No restrictions
Therapies / drugs in trial
Locations (82)
Anhui Tumour Hospital
Hefei, China
The first affiliated hospital of Anhui Medical University
Hefei, China
The Second Hospital of Anhui Medical University
Hefei, China
Beijing Cancer hospital
Beijing, China
Beijing Tsinghua Chang Gung Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
Chinese First Affiliated Hospital of Army Medical University of the People's Liberation Army
Chongqing, China
Chongqing University Affiliated Tumor Hospital
Chongqing, China
The first affiliated hospital of Chongqing Medical University
Chongqing, China
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
Xinqiao Hospital of AMU
Chongqing, China
Xinqiao Hospital
Chongqing, China
Fujian Tumor Hospital
Fuzhou, China
Sun Yat-sen University Cancer Center
Guangzhou, China
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
The Sixth Affiliated Hospital of Sun Yat-Sen University
Guangzhou, China
Zhujiang Hospital of Southern Medical University
Guangzhou, China
Meizhou People's Hospital
Meizhou, China
Shantou University Medical College Tumour Hospital
Shantou, China
Guilin Medical College Second Affiliated Hospital
Guilin, China
Guangxi Medical University Cancer Hospital
Nanning, China
Guangxi Medical University Affiliated Tumour Hospital
Nanning, China
The People's Hospital of Guangxi
Nanning, China
Harbin Medical university cancer hospital
Harbin, China
The First Affiliated Hospital Of Henan University&Technology
Luoyang, China
The First Affiliated Hospital of Nanyang Medical College
Nanyang, China
Xinxiang Medical University No.1 Affiliated Hospital
Xinxiang, China
He'nan Cancer Hospital South Gate
Zhengzhou, China
Henan Provincial Chest Hospital
Zhengzhou, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
The First Peoples Hospital of Jingzhou
Jingzhou, China
Hubei Cancer Hospital
Wuhan, China
Tongji Hospital
Wuhan, China
Union Hospital Tongji Medical College HuaZhong University of Science Technology
Wuhan, China
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology
Wuhan, China
Xiangyang Central Hospital
Xiangyang, China
Hu'nan Province Cancer Hospital
Changsha, China
Hunan Provincial People's Hospital
Changsha, China
Xiangya hospital Central South University
Changsha, China
The Third People's Hospital of Hunan Province
Yueyang, China
The Second Affiliated Hospital of Soochow University
Suzhou, China
The Affiliated Hospital of Xuzhou medical University
Xuzhou, China
Xuzhou Central Hospital
Xuzhou, China
First Affiliated Hospital of Gannan Medical University
Ganzhou, China
Jiangxi Cancer Hospital
Nanchang, China
The Affiliated Hospital of NanChang University
Nanchang, China
The Third Hospital of Nanchang
Nanchang, China
Jilin Provincial Cancer Hospital
Changchun, China
China-Japan Union Hospital of Jilin University
Changchun, China
The second Hospital of Dalian Medical University
Dalian, China
Fukuang General Hospital of Liaoning Health Industry Group
Fushun, China
Liaoning Cancer Hospital & Institute
Shenyang, China
The First Hospital of China Medical University Physical Examination Center
Shenyang, China
Shandong Cancer Hospital
Jinan, China
Jinan Central Hospital Affiliated to Shandong University
Jinan, China
Shandong Cancer Hospital
Jinan, China
Shandong Provincial Public Health Clinical Center
Jinan, China
Affiliated Hospital of Jining Medical University
Jining, China
Linyi Cancer hospital
Linyi, China
The Affiliated Hospital of Qingdao University
Qingdao, China
Weifang People's Hospital
Weifang, China
Huashan Hospital affiliated to Fudan University
Shanghai, China
Shanghai General Hospital
Shanghai, China
Shanghai Ninth People's Hospital
Shanghai, China
Shanghai Pulmonary Hospital
Shanghai, China
The Affiliated Huashan Hospital of Fudan University
Shanghai, China
The No.10 Peoples Hospital
Shanghai, China
Shanxi Province Cancer Hospital
Taiyuan, China
The First Affiliated Hospital Of Xi'an JiaoTong University
Xian, China
Sichuan Cancer Hospital
Chengdu, China
SiChuan Cancer Hospital
Chengdu, China
West China Hospital of Sichuan University
Chengdu, China
West China Hospital,Sichuan Universtiy
Chengdu, China
The Affiliated Cancer Hospital of Xinjiang Medical University
Ürümqi, China
Yunnan Tumor Hospital
Kunming, China
The Second Affiliated Hospital of Zhejiang University school of Medicine
Hangzhou, China
ZheJiang Cancer Hospital
Hangzhou, China
Zhejiang Province People's Hospital
Hangzhou, China
Zhejiang Province People's Hospital
Hangzhou, China
Zhejiang University Medical College Affiliated No.1 Hospital
Hangzhou, China
Yiwu Central Hospital
Jinhua, China
Taizhou Hospital of Zhejiang
Taizhou, China
Trial contact
Coordinator Clinical operation director
Clinical Operation derictor
Coordinator Clincial operation director
Coordinator RA
Coordinator Clincial operation director
Coordinator
Coordinator Clinial Operation director
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.